Get it on Google Play

Veltassa Black Box Warning Removed

November 28, 2016 5:57 AM EST

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Galenica Group today announced that Relypsa, Inc., a Vifor Pharma Company, has received approval from the US Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) with important updates to the US label of Veltassa (patiromer) for oral suspension. The US label for Veltassa no longer includes a Boxed Warning regarding the separation of Veltassa and other oral medications.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA

Add Your Comment